相似文献
1
Drug points: severe ergotism associated with interaction between ritonavir and ergotamine.
BMJ. 1999 Mar 20;318(7186):771. doi: 10.1136/bmj.318.7186.771.
2
Clinical ergotism induced by ritonavir.
Scand J Infect Dis. 2001;33(10):788-9. doi: 10.1080/003655401317074699.
3
[Splenic infarction. Ergotism induced by ritonavir?].
Medicina (B Aires). 2012;72(6):475-7.
4
Leg ischemia in a patient receiving ritonavir and ergotamine.
Ann Intern Med. 1999 Feb 16;130(4 Pt 1):329-30. doi: 10.7326/0003-4819-130-4-199902160-00102.
5
[Ergotism and HIV].
Medicina (B Aires). 2013;73(4):346-8.
6
Cerebral ergotism under treatment with ergotamine and ritonavir.
Neurology. 2001 Aug 28;57(4):743-4. doi: 10.1212/wnl.57.4.743.
7
Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient.
Antimicrob Agents Chemother. 1997 May;41(5):1207. doi: 10.1128/AAC.41.5.1207.
8
Headache in an HIV-Positive Patient: Dangerous Interaction.
BMJ Case Rep. 2018 Jun 4;2018:bcr-2018-225130. doi: 10.1136/bcr-2018-225130.
9
Ergotism caused by concurrent use of ritonavir and ergot alkaloids: a case report.
Acta Chir Belg. 2009 Oct;109(5):639-40. doi: 10.1080/00015458.2009.11680505.
10
[Ergotism secondary to ergotamine-ritonavir association. Report of three cases].
Rev Med Chil. 2011 Dec;139(12):1597-600. Epub 2012 Mar 7.
引用本文的文献
1
Nanoparticulate Drug Delivery Strategies to Address Intestinal Cytochrome P450 CYP3A4 Metabolism towards Personalized Medicine.
Pharmaceutics. 2021 Aug 16;13(8):1261. doi: 10.3390/pharmaceutics13081261.
2
Ergot alkaloids produced by endophytic fungi of the genus Epichloë.
Toxins (Basel). 2015 Mar 6;7(3):773-90. doi: 10.3390/toxins7030773.
3
Use of lopinavir/ritonavir associated with ergotamine resulting in foot amputation: brief communication.
Rev Inst Med Trop Sao Paulo. 2014 May-Jun;56(3):265-6. doi: 10.1590/s0036-46652014000300013.
4
Upper limb artery segmental occlusions due to chronic use of ergotamine combined with itraconazole, treated by thrombolysis.
Thromb J. 2011 Aug 30;9:13. doi: 10.1186/1477-9560-9-13.
5
Antagonistic effects of simultaneous exposure of ergot alkaloids on kidney adenosine triphosphatase system.
In Vitro Cell Dev Biol Anim. 2003 Sep-Oct;39(8-9):395-8. doi: 10.1290/1543-706X(2003)039<0395:AEOSEO>2.0.CO;2.
6
Drug interactions between antiretroviral drugs and comedicated agents.
Clin Pharmacokinet. 2003;42(3):223-82. doi: 10.2165/00003088-200342030-00002.
7
Clinically significant drug interactions with agents specific for migraine attacks.
CNS Drugs. 2001;15(2):105-18. doi: 10.2165/00023210-200115020-00003.
8
Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.
Clin Pharmacokinet. 2000 Jan;38(1):41-57. doi: 10.2165/00003088-200038010-00003.
本文引用的文献
1
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2.
Genitourin Med. 1997 Feb;73(1):5-11. doi: 10.1136/sti.73.1.5.
2
Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient.
Antimicrob Agents Chemother. 1997 May;41(5):1207. doi: 10.1128/AAC.41.5.1207.
3
Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction.
Arch Intern Med. 1996 Feb 26;156(4):456-8.
4
Severe iatrogenic ergotism: incidence and clinical importance.
Vasa. 1991;20(2):153-6.
Zotero 插件